![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0214.jpg)
Conclusions HF ca-co study
•
Quantitative estimates
of HF risk in 5-year HL survivors
following RT:
–
Little increase in HF risk for doses up to 25 Gy MHD or up
to 15 Gy MLVD, but HF rates increase rapidly at higher
doses.
•
Anthracyclines: 3-fold increased HF rate, irrespective of the
dose of anthracycline or of cardiac radiation.
•
Our findings can be used to
predict HF risk
➢
Patients who received both anthracyclines + mediastinal RT
need to be followed carefully.